HTLV gene regulation: Because size matters, transcription is not enough

Future Microbiology

Volumn 4, Issue 4, 2009, Pages 425-440

  Journo, Chloé ^a,b,c   Douceron, Estelle ^a,b,c,d   Mahieux, Renaud ^a,b,c  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c University Lyon i   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

Accessory proteins; Acetylation; Alternative splicing; Antisense transcription; HBZ; HTLV; Phosphorylation; Retrovirus; Tax; Ubiquitination

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS 1 BASIC LEUCINE ZIPPER FACTOR; PROTEASOME; REX PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; MESSENGER RNA;

ACETYLATION; ENZYME DEGRADATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS REPLICATION; ACTIVE TRANSPORT; GENE EXPRESSION REGULATION; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 1; METABOLISM; PHYSIOLOGY; PROMOTER REGION; RNA SPLICING;

ANIMALIA; HUMAN T-LYMPHOTROPIC VIRUS 1;

ACTIVE TRANSPORT, CELL NUCLEUS; GENE EXPRESSION REGULATION, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA SPLICING; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 66949171425     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.13     Document Type: Review

References (133)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA 77, 7415-7419 (1980).
2. Takatsuki T: Adult T-Cell leukemia in Japan. In: Topics in Hematology. Seno S, Irino S (Eds). Excerpta Medica, Amsterdam, The Netherlands (1977).
3. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad. Sci. USA 79, 2031-2035 (1982).
4. Gessain A, Barin F, Vernant JC et al.: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410 (1985).
5. Osame M, Izumo S, Igata A et al.: Blood transfusion and HTLV-I associated myelopathy. Lancet 2, 104-105 (1986).
6. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058-6068 (2005).
7. Wolfe ND, Heneine W, Carr JK et al.: Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad. Sci. USA 102, 7994-7999 (2005).
8. Calattini S, Chevalier SA, Duprez R et al.: Discovery of a hew human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2, 30 (2005).
9. Johnson JM, Harrod R, Franchini G: Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int. J. Exp. Pathol. 82, 135-147 (2001).
10. Mesnard JM, Devaux C: Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology 257, 277-284 (1999).
11. de The G, Kazanji M: An HTLV-I/vaccine II: from-animal models to clinical trials? J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1), S191-S198 (1996).
12. Gessain A: Epidemiology of HTLV-1. In: Human T-cell lymphotropic virus type 1. Holsberg P (Ed.). Wiley, Chichester, UK (1996).
13. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P et al.: Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int. J. Cancer 82, 832-836 (1999).
14. Roucoux DF, Wang B, Smith D et al.: A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV. J. Infect. Dis. 191, 1490-1497 (2005).
15. Manns A, Murphy EL, Wilks R et al.: Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood 896-905 (1991).
16. Koyanagi Y, Itoyama Y, Nakamura N et al.: In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196, 25-33 (1993).
17. Hishizawa M, Imada K, Kitawaki T, Ueda M, Kadowaki N, Uchiyama T: Depletion and impaired interferon-α-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br. J. Haematol. 125, 568-575 (2004).
18. Macatonia SE, Cruickshank JK, Rudge P, Knight SC: Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Resu Hum. Retroviruses 8, 1699-1706 (1992).
19. + T lymphocytes naturally infected with human T-cell lymphotropic virus type I. Immunity 13, 657-664 (2000).
20. + T cells. Nat. Med. 14(4), 429-436 (2008).
21. Jassal SR, Pohler RG, Brighty DW: Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein- immunoadhesin. J. Virol. 75, 8317-8328. (2001).
22. + T cells. J. Virol. 79, 12692-12702 (2005).
23. Ghez D, Lepelletier Y, Lambert S et al.: Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80, 6844-6854 (2006).
24. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL: The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449-459 (2003).
25. Lambert S, Bouttier M, Vassy R et al.: HTLV-1 uses HSPG and neuropilin 1 for entry by molecular mimicry of VEGF165. Blood (2009).
26. Igakura T, Stinchcombe JC, Goon PK et al.: Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299, 1713-1716 (2003).
27. Majorovits E, Nejmeddine M, Tanaka Y, Taylor GP, Fuller SD, Bangham CR: Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS ONE 3, e2251 (2008).
28. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S: Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69, 2863-2868 (1995).
29. Slattery JP, Franchini G, Gessain A: Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res. 9, 525-540 (1999).
30. Verdonck K, Gonzalez E, van Dooren S, Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 7, 266-281 (2007).
31. Kashanchi F, Brady JN: Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 24, 5938-5951 (2005).
32. Baydoun HH, Bellon M, Nicot C: HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. AIDS Rev. 10, 195-204 (2008).
33. Koralnik IJ, Gessain A, Klotman ME, Lo Monico A, Berneman ZN, Franchini G: Protein isoforms encoded by the pX region of human T-cell leukemia/ lymphotropic virus type I. Proc. Natl Acad. Sci. USA 89, 8813-8817 (1992).
34. Berneman ZN, Gartenhaus RB, Reitz MS Jr et al.: Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl Acad. Sci. USA 89, 3005-3009 (1992).
35. Pique C, Ureta-Vidal A, Gessain K et al.: Evidence for the chronic in vivo production of human T-cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191, 567-572 (2000).
36. Derse D, Mikovits J, Ruscetti F: X-I and X-open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T cells in vitro. Virology 237, 123-128 (1997).
37. Bartoe JT, Albrecht B, Collins ND et al.: Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74, 1094-1100 (2000).
38. Lairmore MD, Albrecht B, D'Souza C et al.: In vitro and in vivo functional analysis of human T-cell lymphotropic virus type 1 pX open reading frames I and II. AIDS Res. Hum. Retroviruses 16, 1757-1764 (2000).
39. Albrecht B, Lairmore MD: Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol. Mol. Biol. Rev. 66, 356-406, table of contents (2002).
40. Ding W, Albrecht B, Luo R et al.: Endoplismic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J. Virol. 75, 7672-7682 (2001).
41. Johnson JM, Nicot C, Fullen J et al.: Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J. Virol. 75, 6086-6094 (2001).
42. Ding W, Albrecht B, Kelley RE et al.: Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 76, 10374-10382 (2002).
43. Fukumoto R, Dundr M, Nicot C et al.: Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1. J. Virol. 81, 9088-9099 (2007).
44. Fukumoto R, Andresen V, Bialuk I et al.: In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood (2008).
45. Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK: Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J. Virol. 66, 1737-1745 (1992).
46. Nicot C, Harrod RL, Ciminale V, Franchini G: Human T-cell leukemia/ lymphoma virus type 1 nonstructural genes and their functions. Oncogene 24, 6026-6034 (2005).
47. Hiraragi H, Kim SJ, Phipps AJ et al.: Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J. Virol., 3469-3476 (2006).
48. D'Agostino DM, Ranzato L, Arrigoni G et al.: Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J. Biol. Chem. 277, 34424-34433 (2002).
49. Silic-Benussi M, Cavallari I, Zorzan T et al.: Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T-cell leukemia virus type 1. Proc. Natl Acad. Sci. USA 101, 6629-6634 (2004).
50. D'Agostino DM, Silic-Benussi M, Hiraragi H, Lairmore MD, Ciminale V: The human T-cell leukemia virus type 1 p13 protein II: effects on mitochondrial function and cell growth. Cell Death Differ. 12(Suppl. 1), 905-915 (2005).
51. Ghorbel S, Sinha-Datta U, Dundr M, Brown M, Franchini G, Nicot C: Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J. Biol. Chem. 281, 37150-37158 (2006).
52. Nicot C, Dundr M, Johnson JM et al.: HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 10, 197-201 (2004).
53. Baydoun H, Duc-Dodon M, Lebrun S, Gazzolo L, Bex F: Regulation of the human T-cell leukemia virus gene expression depends on the localization of regulatory proteins Tax, Rex and p30II in specific nuclear subdomains. Gene 386, 191-201 (2007).
54. Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL: Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J. Virol. 78, 11077-11083 (2004).
55. Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7, 270-280 (2007).
56. Nosaka T, Miyazaki Y, Takamatsu T et al.: The post-transcriptional regulator Rex of the human T-cell leukemia virus type I is present as nucleolar speckles in infected cells. Exp. Cell Res. 219, 122-129 (1995).
57. Inoue J, Itoh M, Akizawa T, Toyoshima H, Yoshida M: HTLV-1 Rex protein accumulates unspliced RNA in the nucleus as well as in cytoplasm. Oncogene 6, 1753-1757 (1991).
58. Grone M, Koch C, Grassmann R: The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding-intron excision and degradation. Virology 218, 316-325 (1996).
59. Toyoshima H, Itoh M, Inoue J, Seiki M, Takaku F, Yoshida M: Secondary structure of the human T-cell leukemia virus type 1 rex-responsive element is essential for Rex regulation of RNA processing and transport of unspliced RNAs. J. Virol. 64, 2825-2832 (1990).
60. Unge T, Solomin L, Mellini M, Derse D, Felber BK, Pavlakis GN: The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA. Proc. Natl Acad. Sci. USA 88, 7145-7149 (1991).
61. Grone M, Hoffmann E, Berchtold S, Cullen BR, Grassmann R: A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology 204, 144-152 (1994).
62. Feuer G, Green PL: Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24, 5996-6004 (2005).
63. Fujisawa J, Seiki M, Sato M, Yoshida M: A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I. EMBO J. 5, 713-718 (1986).
64. Suzuki T, Fujisawa JI, Toita M, Yoshida M: The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl Acad. Sci. USA 90, 610-614 (1993).
65. Lairmore MD, Silverman L, Ratner L: Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24, 6005-6015 (2005).
66. Hasegawa H, Sawa H, Lewis MJ et al.: Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 12, 466-472 (2006).
67. Endo K, Hirata A, Iwai K et al.: Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax. J. Virol. 76, 2648-2653 (2002).
68. Taylor JM, Nicot C: HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis 13, 733-747 (2008).
69. Pise-Masison CA, Mahieux R, Radonovich M et al.: Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax. AIDS Res. Hum. Retroviruses 16, 1669-1675 (2000).
70. Goh WC, Sodroski J, Rosen C, Essex M, Haseltine WA: Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. Science 227, 1227-1228 (1985).
71. Uy R, Wold F: Posttranslational covalent modification of proteins. Science 198, 890-896 (1977).
72. Johannessen M, Delghandi MP, Moens U: What turns CREB on? Cell Signal. 16, 1211-1227 (2004).
73. Nyunoya H, Akagi T, Ogura T, Maeda S, Shimotohno K: Evidence for phosphorylation of trans-activator p40x of human T-cell leukemia virus type I produced in insect cells with a baculovirus expression vector. Virology 167, 538-544 (1988).
74. Fontes JD, Strawhecker JM, Bills ND, Lewis RE, Hinrichs SH: Phorbol esters modulate the phosphorylation of human T-cell leukemia virus type I Tax. J. Virol. 67, 4436-4441 (1993).
75. Semmes OJ, Jeang KT: Mutational analysis of human T-cell leukemia virus type Tax I: regions necessary for function determined with 47 mutant proteins. J. Virol. 66, 7183-7192 (1992).
76. Krause Boehm A, Stawhecker JA, Semmes OJ, Jankowski PE, Lewis R, Hinrichs SH: Analysis of potential phosphorylation sites in human T-cell leukemia virus type 1 Tax. J. Biomed. Sci. 6, 206-212 (1999).
77. Bex F, Murphy K, Wattiez R, Burny A, Gaynor RB: Phosphorylation of the human T-cell leukemia virus type 1 transactivator tax on adjacent serine residues is critical for tax activation. J. Virol. 73, 738-745 (1999).
78. Durkin SS, Ward MD, Fryrear KA, Semmes OJ: Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein. J. Biol. Chem. 281, 31705-31712 (2006).
79. Andersson KB, Kowenz-Leutz E, Brendeford EM, Tygsett AH, Leutz A, Gabrielsen OS: Phosphorylation-dependent down-regulation of c-Myb DNA binding is abrogated by a point mutation in the v-myb oncogene. J Biol. Chem. 278, 3816-3824 (2003).
80. Pickart CM: Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 (2001).
81. Weake VM, Workman JL: Histone ubiquitination: triggering gene activity. Mol. Cell. 29, 653-663 (2008).
82. Hetzer C, Dormeyer W, Schnolzer M, Ott M: Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes Infect. 7, 1364-1369 (2005).
83. Hay RT: SUMO: a history of modification. Mol. Cell. 18, 1-12 (2005).
84. Peloponese JM Jr, Iha H, Yedavalli VR et al.: Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity. J. Virol. 78, 11686-11695 (2004).
85. Chiari E, Lamsoul I, Lodewick J, Chopin C, Bex F, Pique C: Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J. Virol. 78, 11823-11832 (2004).
86. Lamsoul I, Lodewick J, Lebrun S et al.: Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-κB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell. Biol. 25, 10391-10406 (2005).
87. Nasr R, Chiari E, El-Sabban M et al.: Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-κB activation. Blood 107, 4021-4029 (2006).
88. Shembade N, Harhaj NS, Yamamoto M, Akira S, Harhaj EW: The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-κB activation. J. Virol. 81, 13735-13742 (2007).
89. Harhaj NS, Sun SC, Harhaj EW: Activation of NF-κB by the human T cell leukemia virus type I Tax oncoprotein is associated with ubiquitin-dependent relocalization of IκB kinase. J. Biol. Chem. 282, 4185-4192 (2007).
90. Alefantis T, Barmak K, Harhaj EW, Grant C, Wigdahl B: Characterization of a nuclear export signal within the human T-cell leukemia virus type I transactivator protein Tax. J. Biol. Chem. 278, 21814-21822 (2003).
91. Chevalier SA, Meertens L, Calattini S, Gessain A, Kiemer L, Mahieux R: Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein. Retrovirology 2, 70 (2005).
92. Huang J, Ren T, Guan H, Jiang Y, Cheng H: HTLV-1 Tax is a critical lipid raft modulator that hijacks IκB kinases to the microdomains for persistent activation of NF-κB. J. Biol. Chem. 284, 6208-6217 (2009).
93. Kfoury Y, Nasr R, Favre-Bonvin A et al.: Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome. Oncogene 27, 1665-1676 (2008).
94. Du JX, Bialkowska AB, McConnell BB, Yang VW: SUMOylation regulates nuclear localization of Kruppel-like factor 5. J. Biol. Chem. 283, 31991-32002 (2008).
95. Gatza ML, Dayaram T, Marriott SJ: Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export. Retrovirology 4, 95 (2007).
96. Beraud C, Greene WC: Interaction of HTLV-I Tax with the human proteasome: implications for NF-κB induction. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 Suppl 1, S76-S84 (1996).
97. Rousset R, Desbois C, Bantignies F, Jalinot P: Effects on NF-κB1/ p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 381, 328-331 (1996).
98. Yan P, Fu J, Qu Z et al.: PDLIM2 suppresses HTLV-I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood (2009).
99. Wertz IE, O'Rourke KM, Zhou H et al.: De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signaling. Nature 430, 694-699 (2004).
100. Zhang SQ, Kovalenko A, Cantarella G, Wallach D: Recruitment of the IKK signalosome to the p55 T receptor NF: RIP and A20 bind to NEMO (IKK-γ) upon receptor stimulation. Immunity 12, 301-311 (2000).
101. Evans PC, Ovaa H, Hamon M et al.: Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378, 727-734 (2004).
102. Shembade N, Harhaj NS, Liebl DJ, Harhaj EW: Essential role for TAX1BP1 in the termination of TNF-α-, IL-1- and LPS-mediated NF-κB and JNK signaling. EMBO J. 26, 3910-3922 (2007).
103. Heyninck K, De Valck D, Vanden Berghe W, et al.: The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J. Cell. Biol. 145, 1471-1482 (1999).
104. Zetoune FS, Murthy AR, Shao Z et al.: A20 inhibits NF-κB activation downstream of multiple Map3 kinases and interacts with the IκB signalosome. Cytokine 15, 282-298 (2001).
105. Shembade N, Harhaj NS, Parvatiyar K et al.: The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9, 254-262 (2008).
106. Yang XJ, Seto E: Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell. 31, 449-461 (2008).
107. Lodewick J, Lamsoul I, Polania A et al.: Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-κB pathway. Virology 386(1), 68-78 (2009).
108. Peloponese JM Jr, Yasunaga J, Kinjo T, Watashi K, Jeang KT: Peptidylproline cis-trans isomerase Pin1 interacts with HTLV-1 Tax and modulates its activation of NF-κB. J. Virol. 83(7), 3238-3248 (2009).
109. Larocca D, Chao LA, Seto MH, Brunck TK: Human T-cell leukemia virus minus strand transcription in infected T cells. Biochem. Biophys. Res. Commun. 163, 1006-1013 (1989).
110. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM: The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 76, 12813-12822 (2002).
111. Cavanagh MH, Landry S, Audet B, et al.: HTLV-I antisense transcripts initiating in the 3′LTR are alternatively spliced and polyadenylated. Retrovirology 3, 15 (2006).
112. Murata K, Hayashibara T, Sugahara K et al.: A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol. 80, 2495-2505 (2006).
113. Yoshida M, Satou Y, Yasunaga J, Fujisawa J, Matsuoka M: Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J. Virol. 82, 9359-9368 (2008).
114. Landry S, Halin M, Vargas A, Lemasson I, Mesnard JM, Barbeau B: Upregulation of HTLV-1 antisense transcription by the viral Tax protein. J. Virol. 83, 2048-2054 (2008).
115. Usui T, Yanagihara K, Tsukasaki K et al.: Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 5, 34 (2008).
116. Saito M, Matsuzaki T, Satou Y et al.: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 6, 19 (2009).
117. Li M, Green PL: Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. J. Virol. Methods 142, 159-168 (2007).
118. Hivin P, Frederic M, Arpin-Andre C et al.: Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J. Cell Sci. 118, 1355-1362 (2005).
119. Hivin P, Basbous J, Raymond F et al.: The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology 4, 14 (2007).
120. Lemasson I, Lewis MR, Polakowski N et al.: Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 81, 1543-1553 (2007).
121. Eferl R, Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868 (2003).
122. Matsumoto J, Ohshima T, Isono O, Shimotohno K: HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 24, 1001-1010 (2005).
123. Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM: The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J. Biol. Chem. 278, 43620-43627 (2003).
124. Isono O, Ohshima T, Saeki Y et al.: Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination. J. Biol. Chem. 283, 34273-34282 (2008).
125. Thebault S, Basbous J, Hivin P, Devaux C, Mesnard JM: HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 562, 165-170 (2004).
126. Kuhlmann AS, Villaudy J, Gazzolo L, Castellazzi M, Mesnard JM, Duc Dodon M: HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 4, 92 (2007).
127. Clerc I, Polakowski N, Andre-Arpin C et al.: An interaction between the human T-cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ. J. Biol. Chem. 283, 23903-23913 (2008).
128. Zhao T, Yasunaga JI, Satou Y et al.: Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB. Blood (2008).
129. Satou Y, Yasunaga J, Yoshida M, Matsuoka M: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T-cell leukemia cells. Proc. Natl Acad. Sci. USA 103, 720-725 (2006).
130. Miyazaki M, Yasunaga J, Taniguchi Y, Tamiya S, Nakahata T, Matsuoka M: Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5′ long terminal repeat during oncogenesis. J. Virol. 81, 5714-5723 (2007).
131. Arnold J, Yamamoto B, Li M et al.: Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107, 3976-3982 (2006).
132. Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL: Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 112, 3788-3797 (2008).
133. Saitoh Y, Yamamoto N, Dewan MZ et al.: Overexpressed NF-κB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood 111, 5118-5129 (2008).